Loading organizations...
§ Private Profile · San Francisco, CA, USA
Precision medicine software company offering cloud-based platforms for optimizing drug dosing and clinical analytics for health systems.
InsightRX, based in San Francisco, California, develops cloud-based precision medicine software that leverages pharmacology models, artificial intelligence, and patient-specific data to optimize treatment decisions. Its core platforms, InsightRX Nova for individualizing drug dosing and InsightRX Apollo for real-time clinical analytics, integrate into clinical workflows for healthcare providers and biopharma companies, improving patient outcomes. The company has secured $13 million in total funding and currently offers 139 distinct pharmacology models, reporting accelerated growth in platform usage throughout 2022. InsightRX's SaaS platform subscriptions support model-informed precision dosing (MIPD) in clinical settings, facilitating more precise and effective patient care across diverse therapeutic areas. The organization was founded in 2015 by Sirj Goswami, Ron Keizer, and Ranvir Mangat. Its business model centers on saaS platform subscriptions or licensing to health systems and biopharma companies.
InsightRX has raised $10.0M across 1 funding round.
InsightRX has raised $10.0M in total across 1 funding round.
InsightRX has raised $10.0M in total across 1 funding round.
InsightRX's investors include Mark Bakken, GreatPoint Ventures, Leawood Venture Capital, OSF Healthcare, Premier, Rock Health.
InsightRX has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in September 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 19, 2019 | $10M Series A | Mark Bakken | GreatPoint Ventures, Leawood Venture Capital, OSF Healthcare, Premier, Rock Health | Announced |